A twelve-month comparative clinical investigation of two low-dose oral contraceptives containing 20 μg ethinylestradiol/75 μg gestodene and 30 μg ethinylestradiol/75 μg gestodene, with respect to efficacy, cycle control, and toleranceENDRIKAT, J; MÜLLER, U; DÜSTERBERG, B et al.Contraception (Stoneham). 1997, Vol 55, Num 3, pp 131-137, issn 0010-7824Article

A randomized study over 13 cycles to assess the influence of oral contraceptives containing ethinylestradiol combined with drospirenone or desogestrel on carbohydrate metabolismGASPARD, U; SCHEEN, A; ENDRIKAT, J et al.Contraception (Stoneham). 2003, Vol 67, Num 6, pp 423-429, issn 0010-7824, 7 p.Article

A double-blind comparative study of the effects of a 23-day oral contraceptive regimen with 20 μg ethinyl estradiol and 75 μg gestodene and a 21-day regimen with 30 μg ethinyl estradiol and 75 μg gestodene on hemostatic variables, lipids, and carbohydrate metabolismENDRIKAT, J; KLIPPING, C; GERLINGER, C et al.Contraception (Stoneham). 2001, Vol 64, Num 4, pp 235-241, issn 0010-7824Article

Double-blind, multicenter comparison of efficacy, cycle control, and tolerability of a 23-day versus a 21-day low-dose oral contraceptive regimen containing 20 μg ethinyl estradiol and 75 μg gestodeneENDRIKAT, J; CRONIN, M; GERLINGER, C et al.Contraception (Stoneham). 2001, Vol 64, Num 2, pp 99-105, issn 0010-7824Article

An open label, comparative study of the effects of a dose-reduced oral contraceptive containing 20 μg ethinyl estradiol and 100 μg levonorgestrel on hemostatic, lipids, and carbohydrate metabolism variablesENDRIKAT, J; KLIPPING, C; CRONIN, M et al.Contraception (Stoneham). 2002, Vol 65, Num 3, pp 215-221, issn 0010-7824Article

Impact of oral contraceptive use on APC-resistance: a prospective, randomized clinical trial with three low-dose preparationsENDRIKAT, J; NOAH, M; GERLINGER, C et al.Contraception (Stoneham). 2001, Vol 64, Num 4, pp 217-222, issn 0010-7824Article

A 3-year double-blind, randomized, controlled study on the influence of two oral contraceptives containing either 20 μg or 30 μg ethinylestradiol in combination with levonorgestrel on bone mineral densityENDRIKAT, J; MIH, E; DÜSTERBERG, B et al.Contraception (Stoneham). 2004, Vol 69, Num 3, pp 179-187, issn 0010-7824, 9 p.Article

Multicenter, comparative study of cycle control, efficacy and tolerability of two low-dose oral contraceptives containing 20 μg ethinylestradiol/100 μg levonorgestrel and 20 μg ethinylestradiol/500 μg norethisteroneENDRIKAT, J; HITE, R; BANNEMERSCHULT, R et al.Contraception (Stoneham). 2001, Vol 64, Num 1, pp 3-10, issn 0010-7824Article

Open, multicenter comparison of efficacy, cycle control, and tolerability of a 23-day oral contraceptive regimen with 20 μg ethinyl estradiol and 75 μg gestodene and a 21-day regimen with 20 μg ethinyl estradiol and 150 μg desogestrelENDRIKAT, J; CRONIN, M; GERLINGER, C et al.Contraception (Stoneham). 2001, Vol 64, Num 3, pp 201-207, issn 0010-7824Article

A comparative study of the effects of the hemostatic system of two monophasic gestodene oral contraceptives containing 20 μg and 30 μg ethinylestradiolWINKLER, U. H; SCHINDLER, A. E; ENDRIKAT, J et al.Contraception (Stoneham). 1996, Vol 53, Num 2, pp 75-84, issn 0010-7824Article

A randomized study on the influence of oral contraceptives containing ethinylestradiol combined with drospirenone or desogestrel on lipid and lipoprotein metabolism over a period of 13 cyclesGASPARD, U; ENDRIKAT, J; DESAGER, J. P et al.Contraception (Stoneham). 2004, Vol 69, Num 4, pp 271-278, issn 0010-7824, 8 p.Article

A meta-analysis on the correlation between ovarian activity and the incidence of intermenstrual bleeding during low-dose oral contraceptive useENDRIKAT, J; GERLINGER, C; PLETTIG, K et al.Gynecological endocrinology. 2003, Vol 17, Num 2, pp 107-114, issn 0951-3590, 8 p.Article

Comparison of efficacy, cycle control, and tolerability of two low-dose oral contraceptives in a multicenter clinical studyENDRIKAT, J; DÜSTERBERG, B; RUEBIG, A et al.Contraception (Stoneham). 1999, Vol 60, Num 5, pp 269-274, issn 0010-7824Article

A twelve-month comparative clinical investigation of two low-dose oral contraceptives containing 20 μg ethinylestradiol/75 μg gestodene and 20 μg ethinylestradiol/150 μg desogestrel, with respect to efficacy, cycle control and toleranceENDRIKAT, J; JAQUES, M.-A; MAYERHOFER, M et al.Contraception (Stoneham). 1995, Vol 52, Num 4, pp 229-235, issn 0010-7824Article